An additional study by Wang et al. discovered that whereas relatively high expression of ZSCAN18 is linked to a favorable prognosis, DNA methylation-modified ZSCAN18 is underexpressed in breast tumors. The gene discussed is ZSCAN18; the disease is breast neoplasm.